Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Jonathan Palmer, Ben Messer & Michelle Ramsay. (2022) Tracheostomy ventilation in motor neurone disease: a snapshot of UK practice. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:1-2, pages 35-41.
Read now
Read now
Esther T. Kruitwagen-Van Reenen, Eline W. M. Scholten, Annerieke van Groenestijn, Leonard H. Van Den Berg, Marcel W. M. Post & Johanna Visser-Meily. (2021) Participation and autonomy in the first 10 months after diagnosis of ALS: a longitudinal study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:7-8, pages 459-466.
Read now
Read now
. (2019) Theme 9 Clinical trials and trial design. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:sup1, pages 262-288.
Read now
Read now
. (2018) Theme 12 Respiratory and nutritional management. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:sup1, pages 325-352.
Read now
Read now
Crystal Jing Jing Yeo & Zachary Simmons. (2018) Discussing edaravone with the ALS patient: an ethical framework from a U.S. perspective. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:3-4, pages 167-172.
Read now
Read now
Articles from other publishers (21)
Christina Martin Schaff, Jerome E. Kurent, Sherry Kolodziejczak, Michelle Milic, Laura A. Foster & Ambereen K. Mehta. (2023) Neuroprognostication for Patients with Amyotrophic Lateral Sclerosis: An Updated, Evidence-Based Review. Seminars in Neurology 43:05, pages 776-790.
Crossref
Crossref
Kathryn A. KvamMichael BenatarAlisa BrownleeTracie CallerRohit R. DasPhil GreenSherry KolodziejczakJohn RussoDanica SandersNadia SethiKara StavrosJulie StierwaltNancy Giles WaltersAmy BennettScott R. WesselsBenjamin Rix Brooks. (2023) Amyotrophic Lateral Sclerosis Quality Measurement Set 2022 Update. Neurology 101:5, pages 223-232.
Crossref
Crossref
Benjamin Rix Brooks, Erik P. Pioro, Takeshi Sakata, Fumihiro Takahashi, Melissa Hagan & Stephen Apple. (2023) The effects of intervention with intravenous edaravone in Study 19 on hospitalization, tracheostomy, ventilation, and death in patients with amyotrophic lateral sclerosis. Muscle & Nerve.
Crossref
Crossref
Mariska J. Vansteensel, Eran Klein, Ghislaine van Thiel, Michael Gaytant, Zachary Simmons, Jonathan R. Wolpaw & Theresa M. Vaughan. (2022) Towards clinical application of implantable brain–computer interfaces for people with late-stage ALS: medical and ethical considerations. Journal of Neurology 270:3, pages 1323-1336.
Crossref
Crossref
Shiori Kato & Mitsuko Ushikubo. (2022) Home Visiting Nurses’ Experience and Views on Morphine Use for Terminally Ill Patients with Amyotrophic Lateral Sclerosis. The Kitakanto Medical Journal 72:2, pages 147-152.
Crossref
Crossref
Daisuke Baba, Naoto Jingami, Takuma Minami, Kwiyoung Park, Ryosuke Takahashi & Shigeru Ohtsuru. (2022) A case of amyotrophic lateral sclerosis presenting with rapid progression of respiratory deterioration due to severe obesity高度肥満で急速に呼吸不全が進行した筋萎縮性側索硬化症の1例. Rinsho Shinkeigaku 62:8, pages 602-608.
Crossref
Crossref
Hidetoshi Shimizu, Yukiko Nishimura, Youichi Shiide, Kaori Yoshida, Manabu Hirai, Munetomo Matsuda, Yoshinobu Nakamaru, Yuichiro Kato & Kazuoki Kondo. (2021) Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects. Clinical Pharmacology in Drug Development 10:10, pages 1188-1197.
Crossref
Crossref
Hidetoshi Shimizu, Yukiko Nishimura, Yoichi Shiide, Hideaki Matsuda, Makoto Akimoto, Munetomo Matsuda, Yoshinobu Nakamaru, Yuichiro Kato & Kazuoki Kondo. (2021) Evaluation of Pharmacokinetics, Safety, and Drug‐Drug Interactions of an Oral Suspension of Edaravone in Healthy Adults. Clinical Pharmacology in Drug Development 10:10, pages 1174-1187.
Crossref
Crossref
Elena Obrador, Rosario Salvador-Palmer, Rafael López-Blanch, Ali Jihad-Jebbar, Soraya L. Vallés & José M. Estrela. (2021) The Link between Oxidative Stress, Redox Status, Bioenergetics and Mitochondria in the Pathophysiology of ALS. International Journal of Molecular Sciences 22:12, pages 6352.
Crossref
Crossref
Toshio Saito, Satoshi Kuru, Toshiaki Takahashi, Mikiya Suzuki & Katsuhisa Ogata. (2021) Changing medical care for amyotrophic lateral sclerosis patients and cause of death — review of muscular dystrophy wards (1999–2013)国内筋ジストロフィー専門入院施設における筋萎縮性側索硬化症医療の変遷と死因―1999～2013年―. Rinsho Shinkeigaku 61:3, pages 161-165.
Crossref
Crossref
John Turnbull. (2020) Reappraisal of an ALS trial: unaccounted procedural risk. The Lancet Neurology 19:9, pages 717-718.
Crossref
Crossref
Denise EppsJustin Y. KwanJames W. Russell, Talisa ThomasMontserrat Diaz-Abad. (2020) Evaluation and Management of Dysphagia in Amyotrophic Lateral Sclerosis: A Survey of Speech-Language Pathologists' Clinical Practice. Journal of Clinical Neuromuscular Disease 21:3, pages 135-143.
Crossref
Crossref
Jin-Mo Park, Sun-Young Kim, Donghwi Park & Jin-Sung Park. (2019) Effect of edaravone therapy in Korean amyotrophic lateral sclerosis (ALS) patients. Neurological Sciences 41:1, pages 119-123.
Crossref
Crossref
Martin R Turner, Christina Faull, Christopher J McDermott, Annabel H Nickol, Jonathan Palmer & Kevin Talbot. (2019) Tracheostomy in motor neurone disease. Practical Neurology 19:6, pages 467-475.
Crossref
Crossref
Josep Darbà. (2019) Current status and direct medical cost of amyotrophic lateral sclerosis in the region of Catalonia: A population-based analysis. PLOS ONE 14:10, pages e0223772.
Crossref
Crossref
Julia L. Agne & Kavitha P. Norton. (2018) Walking but Not Talking: Laryngeal Separation as a Novel Approach to Improve Quality of Life in Bulbar Amyotrophic Lateral Sclerosis. Journal of Pain and Symptom Management 56:6, pages e4-e5.
Crossref
Crossref
Junko Ito, Tetsuro Shimada, Mari Tada, Hiroshi Shimizu, Masatoshi Wakabayashi, Akio Yokoseki, Osamu Onodera, Hitoshi Takahashi & Akiyoshi Kakita. (2018) Clinicopathologic Features of Two Patients With Sporadic Amyotrophic Lateral Sclerosis Who Maintained Communication Ability for Over 30 Years. Journal of Neuropathology & Experimental Neurology 77:11, pages 981-986.
Crossref
Crossref
Victoria L. Hodgkinson, Josh Lounsberry, Ario Mirian, Angela Genge, Timothy Benstead, Hannah Briemberg, Ian Grant, Walter Hader, Wendy S. Johnston, Sanjay Kalra, Gary Linassi, Rami Massie, Michel Melanson, Colleen O’Connell, Kerri Schellenberg, Christen Shoesmith, Sean Taylor, Scott Worley, Lorne Zinman & Lawrence Korngut. (2018) Provincial Differences in the Diagnosis and Care of Amyotrophic Lateral Sclerosis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 45:6, pages 652-659.
Crossref
Crossref
Andrew T. Braun, Candelaria Caballero-Eraso & Noah Lechtzin. (2018) Amyotrophic Lateral Sclerosis and the Respiratory System. Clinics in Chest Medicine 39:2, pages 391-400.
Crossref
Crossref
Amit U Joshi, Nay L Saw, Hannes Vogel, Anna D Cunnigham, Mehrdad Shamloo & Daria Mochly‐Rosen. (2018) Inhibition of Drp1/Fis1 interaction slows progression of amyotrophic lateral sclerosis. EMBO Molecular Medicine 10:3.
Crossref
Crossref
Magdalena Kuźma-Kozakiewicz. (2018) Edaravone in the treatment of amyotrophic lateral sclerosis. Neurologia i Neurochirurgia Polska 52:2, pages 124-128.
Crossref
Crossref